Centre for Oral Clinical Research, Institute of Dentistry, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL), London, UK.
Department of Medicine and Surgery, Centre of Dentistry, University of Parma, Parma, Italy.
Clin Oral Investig. 2023 Nov;27(11):6279-6290. doi: 10.1007/s00784-023-05242-5. Epub 2023 Sep 23.
This systematic review assessed the available evidence on the survival and success rate of zirconia and titanium implants. As secondary outcomes, aesthetic, radiographic and clinical parameters, as well as biological and mechanical complications, were considered.
A systematic search was performed up to March 2022 to identify CCTs/RCTs comparing zirconia and titanium implants with a minimum of 12 months of follow-up. Meta-analysis was performed when ≥ 2 articles with similar characteristics were retrieved.
Four published articles with two RCTs (2 different patient populations) with 100 zirconia and 99 titanium implants that were followed up over 12-80 months were selected out of the 6040 articles. A non-statistically significant difference between zirconia and titanium implant survival at 12 months was suggested (P = 0.0938). The success rates were 57.5-93.3% and 57.1-100% for zirconia and titanium implants, respectively. The pink aesthetic score (PES) was higher for zirconia (10.33 ± 2.06 to 11.38 ± 0.92) compared to titanium implants (8.14 ± 3.58 to 11.56 ± 1.0).
Based on the 2 RCTs retrieved in the literature, similar survival rates were reported for zirconia and titanium implants in the short term (12 months of follow-up). Future RCTs are warranted to evaluate the long-term outcomes of zirconia implants.
Zirconia implants may be the procedure of choice, particularly in the aesthetic zone, since they show a similar survival and success rate as titanium implants on a short-term follow-up.
Systematic review registration number-CRD42021288704 (PROSPERO).
本系统评价评估了氧化锆和钛种植体的存活率和成功率的现有证据。作为次要结果,考虑了美学、放射学和临床参数以及生物学和机械并发症。
截至 2022 年 3 月,进行了系统检索,以确定比较氧化锆和钛种植体且随访时间至少 12 个月的 CCTs/RCTs。当检索到 2 篇具有相似特征的文章时,进行了荟萃分析。
从 6040 篇文章中,选择了 4 篇发表的文章,其中包括 2 项 RCT(2 个不同的患者群体),共涉及 100 个氧化锆和 99 个钛种植体,随访时间为 12-80 个月。12 个月时,氧化锆和钛种植体的存活率之间无统计学显著差异(P=0.0938)。氧化锆和钛种植体的成功率分别为 57.5-93.3%和 57.1-100%。氧化锆种植体的粉色美学评分(PES)较高(10.33±2.06 至 11.38±0.92),而钛种植体则较低(8.14±3.58 至 11.56±1.0)。
根据文献中检索到的 2 项 RCT,在短期(12 个月的随访)内,氧化锆和钛种植体的存活率相似。需要进一步的 RCT 来评估氧化锆种植体的长期结果。
在短期随访中,氧化锆种植体可能是首选方法,特别是在美学区域,因为它们在存活率和成功率方面与钛种植体相似。
系统评价注册号-CRD42021288704(PROSPERO)。